Death due to bioterrorism-related inhalational anthrax: Report of 2 Patients

Luciana Borio, Dennis Frank, Venkat Mani, Carlos Chiriboga, Michael Pollanen, Mary Ripple, Syed Ali, Constance DiAngelo, Jacqueline Lee, Jonathan Arden, Jack Titus, David Fowler, Tara O'Toole, Henry Masur, John Bartlett, Thomas Inglesby

Research output: Contribution to journalArticle

Abstract

On October 9, 2001, a letter containing anthrax spores was mailed from New Jersey to Washington, DC. The letter was processed at a major postal facility in Washington, DC, and opened in the Senate's Hart Office Building on October 15. Between October 19 and October 26, there were 5 cases of inhalational anthrax among postal workers who were employed at that major facility or who handled bulk mail originating from that facility. The cases of 2 postal workers who died of inhalational anthrax are reported here. Both patients had nonspecific prodromal illnesses. One patient developed predominantly gastrointestinal symptoms, including nausea, vomiting, and abdominal pain. The other patient had a "flulike" illness associated with myalgias and malaise. Both patients ultimately developed dyspnea, retrosternal chest pressure, and respiratory failure requiring mechanical ventilation. Leukocytosis and hemoconcentration were noted in both cases prior to death. Both patients had evidence of mediastinitis and extensive pulmonary infiltrates late in their course of illness. The durations of illness were 7 days and 5 days from onset of symptoms to death; both patients died within 24 hours of hospitalization. Without a clinician's high index of suspicion, the diagnosis of inhalational anthrax is difficult during nonspecific prodromal illness. Clinicians have an urgent need for prompt communication of vital epidemiologic information that could focus their diagnostic evaluation. Rapid diagnostic assays to distinguish more common infectious processes from agents of bioterrorism also could improve management strategies.

Original languageEnglish (US)
Pages (from-to)2554-2559
Number of pages6
JournalJournal of the American Medical Association
Volume286
Issue number20
StatePublished - Nov 28 2001

Fingerprint

Bioterrorism
Anthrax
Biological Warfare Agents
Mediastinitis
Myalgia
Leukocytosis
Postal Service
Spores
Artificial Respiration
Respiratory Insufficiency
Dyspnea
Nausea
Abdominal Pain
Vomiting
Hospitalization
Thorax
Communication
Pressure
Lung

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Borio, L., Frank, D., Mani, V., Chiriboga, C., Pollanen, M., Ripple, M., ... Inglesby, T. (2001). Death due to bioterrorism-related inhalational anthrax: Report of 2 Patients. Journal of the American Medical Association, 286(20), 2554-2559.

Death due to bioterrorism-related inhalational anthrax : Report of 2 Patients. / Borio, Luciana; Frank, Dennis; Mani, Venkat; Chiriboga, Carlos; Pollanen, Michael; Ripple, Mary; Ali, Syed; DiAngelo, Constance; Lee, Jacqueline; Arden, Jonathan; Titus, Jack; Fowler, David; O'Toole, Tara; Masur, Henry; Bartlett, John; Inglesby, Thomas.

In: Journal of the American Medical Association, Vol. 286, No. 20, 28.11.2001, p. 2554-2559.

Research output: Contribution to journalArticle

Borio, L, Frank, D, Mani, V, Chiriboga, C, Pollanen, M, Ripple, M, Ali, S, DiAngelo, C, Lee, J, Arden, J, Titus, J, Fowler, D, O'Toole, T, Masur, H, Bartlett, J & Inglesby, T 2001, 'Death due to bioterrorism-related inhalational anthrax: Report of 2 Patients', Journal of the American Medical Association, vol. 286, no. 20, pp. 2554-2559.
Borio L, Frank D, Mani V, Chiriboga C, Pollanen M, Ripple M et al. Death due to bioterrorism-related inhalational anthrax: Report of 2 Patients. Journal of the American Medical Association. 2001 Nov 28;286(20):2554-2559.
Borio, Luciana ; Frank, Dennis ; Mani, Venkat ; Chiriboga, Carlos ; Pollanen, Michael ; Ripple, Mary ; Ali, Syed ; DiAngelo, Constance ; Lee, Jacqueline ; Arden, Jonathan ; Titus, Jack ; Fowler, David ; O'Toole, Tara ; Masur, Henry ; Bartlett, John ; Inglesby, Thomas. / Death due to bioterrorism-related inhalational anthrax : Report of 2 Patients. In: Journal of the American Medical Association. 2001 ; Vol. 286, No. 20. pp. 2554-2559.
@article{4b66f73d0ab4443e9a501e07d448eee4,
title = "Death due to bioterrorism-related inhalational anthrax: Report of 2 Patients",
abstract = "On October 9, 2001, a letter containing anthrax spores was mailed from New Jersey to Washington, DC. The letter was processed at a major postal facility in Washington, DC, and opened in the Senate's Hart Office Building on October 15. Between October 19 and October 26, there were 5 cases of inhalational anthrax among postal workers who were employed at that major facility or who handled bulk mail originating from that facility. The cases of 2 postal workers who died of inhalational anthrax are reported here. Both patients had nonspecific prodromal illnesses. One patient developed predominantly gastrointestinal symptoms, including nausea, vomiting, and abdominal pain. The other patient had a {"}flulike{"} illness associated with myalgias and malaise. Both patients ultimately developed dyspnea, retrosternal chest pressure, and respiratory failure requiring mechanical ventilation. Leukocytosis and hemoconcentration were noted in both cases prior to death. Both patients had evidence of mediastinitis and extensive pulmonary infiltrates late in their course of illness. The durations of illness were 7 days and 5 days from onset of symptoms to death; both patients died within 24 hours of hospitalization. Without a clinician's high index of suspicion, the diagnosis of inhalational anthrax is difficult during nonspecific prodromal illness. Clinicians have an urgent need for prompt communication of vital epidemiologic information that could focus their diagnostic evaluation. Rapid diagnostic assays to distinguish more common infectious processes from agents of bioterrorism also could improve management strategies.",
author = "Luciana Borio and Dennis Frank and Venkat Mani and Carlos Chiriboga and Michael Pollanen and Mary Ripple and Syed Ali and Constance DiAngelo and Jacqueline Lee and Jonathan Arden and Jack Titus and David Fowler and Tara O'Toole and Henry Masur and John Bartlett and Thomas Inglesby",
year = "2001",
month = "11",
day = "28",
language = "English (US)",
volume = "286",
pages = "2554--2559",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "20",

}

TY - JOUR

T1 - Death due to bioterrorism-related inhalational anthrax

T2 - Report of 2 Patients

AU - Borio, Luciana

AU - Frank, Dennis

AU - Mani, Venkat

AU - Chiriboga, Carlos

AU - Pollanen, Michael

AU - Ripple, Mary

AU - Ali, Syed

AU - DiAngelo, Constance

AU - Lee, Jacqueline

AU - Arden, Jonathan

AU - Titus, Jack

AU - Fowler, David

AU - O'Toole, Tara

AU - Masur, Henry

AU - Bartlett, John

AU - Inglesby, Thomas

PY - 2001/11/28

Y1 - 2001/11/28

N2 - On October 9, 2001, a letter containing anthrax spores was mailed from New Jersey to Washington, DC. The letter was processed at a major postal facility in Washington, DC, and opened in the Senate's Hart Office Building on October 15. Between October 19 and October 26, there were 5 cases of inhalational anthrax among postal workers who were employed at that major facility or who handled bulk mail originating from that facility. The cases of 2 postal workers who died of inhalational anthrax are reported here. Both patients had nonspecific prodromal illnesses. One patient developed predominantly gastrointestinal symptoms, including nausea, vomiting, and abdominal pain. The other patient had a "flulike" illness associated with myalgias and malaise. Both patients ultimately developed dyspnea, retrosternal chest pressure, and respiratory failure requiring mechanical ventilation. Leukocytosis and hemoconcentration were noted in both cases prior to death. Both patients had evidence of mediastinitis and extensive pulmonary infiltrates late in their course of illness. The durations of illness were 7 days and 5 days from onset of symptoms to death; both patients died within 24 hours of hospitalization. Without a clinician's high index of suspicion, the diagnosis of inhalational anthrax is difficult during nonspecific prodromal illness. Clinicians have an urgent need for prompt communication of vital epidemiologic information that could focus their diagnostic evaluation. Rapid diagnostic assays to distinguish more common infectious processes from agents of bioterrorism also could improve management strategies.

AB - On October 9, 2001, a letter containing anthrax spores was mailed from New Jersey to Washington, DC. The letter was processed at a major postal facility in Washington, DC, and opened in the Senate's Hart Office Building on October 15. Between October 19 and October 26, there were 5 cases of inhalational anthrax among postal workers who were employed at that major facility or who handled bulk mail originating from that facility. The cases of 2 postal workers who died of inhalational anthrax are reported here. Both patients had nonspecific prodromal illnesses. One patient developed predominantly gastrointestinal symptoms, including nausea, vomiting, and abdominal pain. The other patient had a "flulike" illness associated with myalgias and malaise. Both patients ultimately developed dyspnea, retrosternal chest pressure, and respiratory failure requiring mechanical ventilation. Leukocytosis and hemoconcentration were noted in both cases prior to death. Both patients had evidence of mediastinitis and extensive pulmonary infiltrates late in their course of illness. The durations of illness were 7 days and 5 days from onset of symptoms to death; both patients died within 24 hours of hospitalization. Without a clinician's high index of suspicion, the diagnosis of inhalational anthrax is difficult during nonspecific prodromal illness. Clinicians have an urgent need for prompt communication of vital epidemiologic information that could focus their diagnostic evaluation. Rapid diagnostic assays to distinguish more common infectious processes from agents of bioterrorism also could improve management strategies.

UR - http://www.scopus.com/inward/record.url?scp=0035965626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035965626&partnerID=8YFLogxK

M3 - Article

C2 - 11722269

AN - SCOPUS:0035965626

VL - 286

SP - 2554

EP - 2559

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 20

ER -